In addition, we found that the SGLT inhibitor had no obvious effect on 18F-FDG level in tumor tissue, which is in agreement with a previous report that SGLT1/2 has little influence on the transfer of 18F-FDG to tumor cells11. This evidence concerns the gene SLC5A1 and neoplasm.